Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

Discovery of novel pH transistor nanoprobe for cancer specific detection of malignant tumours

Dec. 23, 2016

First patient dosed in phase II/III trial of 18F-DCFPyL imaging agent

Dec. 9, 2016

Data validate SIME Dx's lung maturity test for identifying infants at risk of RDS

Nov. 28, 2016

Navidea signs Lymphoseek asset purchase agreement with Cardinal Health

Nov. 24, 2016

Aurora Diagnostics selected to provide Ventana PD-L1 Assay in U.S.

Nov. 16, 2016

CellMax-DNA Genetic Cancer Risk Test available in India

Nov. 16, 2016

Seegene and Institut Catala d'Oncologia collaborate on cancer diagnostics

Nov. 16, 2016

MabVax Therapeutics reports progress in MVT-5873 and MVT-2163 programs

Nov. 16, 2016

OpGen collaborates with Merck & Co. on rapid diagnostics to tackle antibiotic resistance

Nov. 15, 2016

FDA transfers EUA for ReEBOV Ebola Antigen Rapid Test to Zalgen

Nov. 15, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...